Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9607 posts found.

novartis_pic

Novartis acquires Admune Therapeutics

October 21, 2015 Research and Development Admune Therapeutics, Cancer, Novartis, Palobiofarma, immunotherapy

Novartis is broadening its portfolio of cancer immunotherapies with the acquisition of Admune Therapeutics, and signing licensing agreements with Palobiofarma …
News
nhs_sign

NHS research activity on the rise

October 21, 2015 Research and Development

NHS England has achieved a significant increase in clinical research over the last year, according to new data from The …
News
dominaix_scientist

Domainex and Imperial College London partner on heart attack treatments

October 20, 2015 Research and Development Domainex cardiac arrest

Drug discovery company Domainex and Imperial College London have announced a new partnership aimed at discovering novel therapies to treat …
News
nuevolution_logo

Nuevolution, Johnson & Johnson begin discovery collaboration

October 19, 2015 Manufacturing and Production, Research and Development Chemetics, Janssen Biotech, Nuevolution

Nuevolution and Janssen Biotech have entered into a collaboration which will use Nuevolution’s Chemetics drug discovery platform to facilitate discovery …
News
regeneron

Regeneron to invest $350 million, create 200 jobs in Ireland

October 19, 2015 Manufacturing and Production, Research and Development

US pharma company Regeneron has announced plans to invest $350 million into its production facility in Limerick, Ireland, creating 200 …
News
onglyza

FDA rejects AstraZeneca diabetes combination

October 16, 2015 Research and Development, Sales and Marketing AstraZeneca, FDA, NDA, dapagliflozin, saxagliptin

The FDA has declined to approve AstraZeneca’s New Drug Application (NDA) for the investigational fixed-dose combination of Onglyza and and …
News
pfizer_logo

Pfizer’s Xeljanz denied plaque psoriasis indication by FDA

October 16, 2015 Research and Development, Sales and Marketing FDA, Pfizer, Xeljanj, tofacitinib

The FDA has rejected the indication expansion of Pfizer’s Xeljanz (tofacitinib) for treatment of moderate to severe cases of plaque psoriasis. …
News
T-cell

$350m collaboration deal for BMS and Five Prime Therapeutics

October 15, 2015 Research and Development BMS, Bristol-Myers Squibb, R&D, five prime, immuno-oncology, tumours

Bristol-Myers Squibb has signed a collaboration agreement with the US biotech firm Five Prime Therapeutics, for a Colony Stimulating Factor …
News
Ablynx flags

Ablynx and Merck begin immuno-oncology collaboration

October 15, 2015 Research and Development Ablynx, Merck, immuno-oncology, nanobody, proof of concept

Ablynx has achieved a pre-clinical proof-of-concept with a nanobody construct as part of its immuno-oncology collaboration with Merck – triggering …
News

Crescendo Biologics appoints Dr Peter Pack as chief exec

October 15, 2015 Business Services, Research and Development

Crescendo Biologics has announced the appointment of Dr Peter Pack as chief executive, who will oversee the company’s new drug …
Appointment
MSD logo

Merck and Incyte to initiate Keytruda, epacadostat combo trial

October 15, 2015 Research and Development Incyte, Merck, R&D, melanoma, phase III, skin cancer

Merck and biopharma firm Incyte are to expand their clinical collaboration to include a Phase III study evaluating the combination …
News
ebola_virus

Johnson & Johnson begins Ebola vaccine trial in Sierra Leone

October 14, 2015 Research and Development Ebola vaccine, Johnson & Johnson

Johnson & Johnson has begun a safety and immunogenicity clinical trial in Sierra Leone of a preventive Ebola vaccine regimen …
News
boris_johnson_in_japan

Mayor of London announces Takeda, UCL R&D partnership

October 14, 2015 Research and Development London, R&D, Takeda, UCL, neurology

Takeda is teaming up with researchers at University College London (UCL) to identify and validate novel target genes for the …
News
erik_j

Lisa Rae Schopf and Erik J. Spek bolster Vedanta Biosciences team

October 14, 2015 Medical Communications, Research and Development

Vedanta Biosciences, a PureTech Health company developing a new class of therapies designed to modulate the human microbiome, has announced …
Appointment

Merck rebrands as ‘science and technology’ company

October 14, 2015 Medical Communications, Research and Development, Sales and Marketing Merck, Merck Millipore, Merck Serono, rebrand, restructure

Merck Group has rebranded to “reflect its transformation into a science and technology company”, and restructured its business to create …
News
The Gateway to Local Adoption Series

Latest content

Stage4You encourages stage 4 bowel cancer patients to prioritise mental health ahead of Bowel Cancer Awareness Month

March 26, 2026

Scotland starts newborn screening for SMA

March 26, 2026

Secarna appoints Jens Holstein and Richard Mark Engelhard to new Advisory Board

March 25, 2026

Roche adds 2,176 NVIDIA Blackwell GPUs to its hybrid-cloud AI factory

March 25, 2026

ReproNovo appoints Mark Altmeyer as Chairman of the Board

March 24, 2026